Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02605213
Recruitment Status : Unknown
Verified November 2015 by Nasser Ebrahim Daryani, Tehran University of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : November 16, 2015
Last Update Posted : November 16, 2015
Information provided by (Responsible Party):
Nasser Ebrahim Daryani, Tehran University of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : February 2016
Estimated Study Completion Date : February 2016